GHK-Cu [Copper tripeptide-1]
Manufacturing and Distribution: The Wild West of Compounded Peptides If BPC-157 isnt an FDA-approved drug or supplement, how are people getting it
__ Agenda The agenda below is tentative, and exact times are subject to change
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
However, there is still insufficient research to strongly state the anti-aging effects of glutathione
10.1016/j.plaphy.2015.11.001 159 TravensoloR